Hemostatic agent use during partial nephrectomy: trends, outcomes, and associated costs
- PDF / 1,081,443 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 49 Downloads / 154 Views
UROLOGY - ORIGINAL PAPER
Hemostatic agent use during partial nephrectomy: trends, outcomes, and associated costs Adri M. Durant1 · Erik Lehman2 · Haley Robyak1 · Suzanne B. Merrill3 · Matthew G. Kaag3 · Jay D. Raman3 Received: 6 April 2020 / Accepted: 8 June 2020 © Springer Nature B.V. 2020
Abstract Purpose To evaluate the ability of hemostatic agents (HA) to limit bleeding complications following partial nephrectomy (PN) and determine HA usage and costs as well as factors associated with post-operative bleeding complications. Methods The records of 429 PN performed for kidney cancers were reviewed for clinical, pathologic, and perioperative variables. Surgical approach, HA use, and HA expenditure were determined. Bleeding complications and management to 90 days after PN were annotated. Wilcoxon rank-sum and two-sample t tests identified factors associated with HA use. Univariate and limited multivariate logistic regression determined variables associated with bleeding complications. Results Use of HA was associated with longer OR duration, longer ischemia time, higher EBL, and method of PN (OPN and LPN > RPN) (all p values
Data Loading...
